| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/09/2008 | US7422846 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
| 09/09/2008 | US7422748 Combining antigen or in vivo generator with a surfactant or with a mixture of surfactants having an overall HLB number of between 5 and 15 and comprising: ethoxylated derivatives of ester of fatty acids and ethoxylated derivatives of oils |
| 09/09/2008 | US7422746 Administering immunity linkers, wherein the linker molecules comprise first binding site and second binding site, wherein second binding site binds to the target and wherein the individual has a pre-existing immune response to first binding site |
| 09/09/2008 | US7422742 Gene therapy using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders, administering antibody or antigen-binding fragment thereof that specifically binds IL-5 |
| 09/09/2008 | US7422740 Capable of inhibiting the cell division cycle in a target cell; for therapy of proliferative cell disorders and intracellular pathogens |
| 09/09/2008 | CA2366205C Biphenyl derivatives |
| 09/09/2008 | CA2323086C Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/09/2008 | CA2287881C Vitamin d3 analogs with bis c-20 side chains |
| 09/09/2008 | CA2135833C Antigen carbohydrate compounds and their use in immunotherapy |
| 09/09/2008 | CA2124677C Immunopotentiatory agents and physiologically acceptable salts thereof |
| 09/04/2008 | WO2008106131A2 Combination therapy for treatment of immune disorders |
| 09/04/2008 | WO2008106116A2 Antagonist ox40 antibodies and their use in the treatment of inflammatory and autoimmune diseases |
| 09/04/2008 | WO2008105920A1 Antihistamine combination |
| 09/04/2008 | WO2008105540A1 Pharmaceutical agent and food effective on allergic disease and autoimmune disease |
| 09/04/2008 | WO2008105526A1 Macrocyclic compound |
| 09/04/2008 | WO2008105504A1 Transdermal immune preparation, method for production of the same, and transdermal immunization method using the same |
| 09/04/2008 | WO2008105498A1 Pharmaceutical composition for ameliorating inflammation induced by il-17 |
| 09/04/2008 | WO2008105386A1 Rexinoid compound having alkoxy group |
| 09/04/2008 | WO2008105384A1 Citrulline-containing tablet |
| 09/04/2008 | WO2008105325A1 Citrulline-containing beverage |
| 09/04/2008 | WO2008105174A1 Liposome for induction of cell-mediated immunity |
| 09/04/2008 | WO2008104124A1 Screening method of combination pharmaceuticals, pharmaceuticals obtained by the method and uses thereof |
| 09/04/2008 | WO2008104077A1 Small molecule inhibitors of protein arginine methyltransferases (prmts) |
| 09/04/2008 | WO2008091954A3 Optimized cd40 antibodies and methods of using the same |
| 09/04/2008 | WO2008071418A3 Use of the endoglycosidase endos for treating immunoglobulin g mediated diseases |
| 09/04/2008 | WO2008062253A3 Stable pharmaceutical compositions of desloratadine and processes for preparation of polymorphic forms of desloratadine |
| 09/04/2008 | WO2008055206A3 Humanized anti-factor d antibodies |
| 09/04/2008 | US20080214781 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 09/04/2008 | US20080214640 3'-{[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid or a salt; treatment of thrombocytopenia; may be coadministered with a colony stimulating factor, cytokine, chemokine, or an interleukin or cytokine receptor agonist or antagonist |
| 09/04/2008 | US20080214591 N-Aryl Diazaspirocyclic Compounds and Methods of Preparation and Use Thereof |
| 09/04/2008 | US20080214585 For abnormal cell proliferation, inflammatory diseases, asthma, and arthritis; (S)-N-{4-[2-(2,4-diamino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-4-methylene-L-glutamic acid disodium salt (CHL1007) |
| 09/04/2008 | US20080214579 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/04/2008 | US20080214575 Piperidine derivatives useful as ccr5 antagonists |
| 09/04/2008 | US20080214546 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 09/04/2008 | US20080214483 Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-beta (TGF-beta) |
| 09/04/2008 | US20080214478 Small Peptides And Methods For Inhibiting The Infiltration Of Eosinophils Into Airways |
| 09/04/2008 | US20080214477 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting t-cell migration; immunotherapy |
| 09/04/2008 | US20080214476 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting mucous release into airways of patients; immunotherapy |
| 09/04/2008 | US20080214475 Small Peptides And Methods For Inhibiting The Mucous Release Into Airways |
| 09/04/2008 | US20080214474 Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease |
| 09/04/2008 | US20080214473 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; treatment and prevention of respiratory system disorders; antiinflammatory agents; immunotherapy |
| 09/04/2008 | US20080214472 Small Peptides And Methods For Treatment Of Arthritis |
| 09/04/2008 | US20080214469 Novel Biologically Active Peptides and Their New Uses |
| 09/04/2008 | US20080214459 Pharmaceutical composition containing sFcyRIIb |
| 09/04/2008 | US20080214452 Method for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using crt translocation |
| 09/04/2008 | US20080213776 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same |
| 09/04/2008 | US20080213319 Using chemorepellents and unimodal fugetaxins as therapeutic tool in treatment of cell proliferative disorders |
| 09/04/2008 | US20080213316 Modify surface of spore to increase adherence to phagocyte; activate phagocytic cells; ingest spore with phagocyte; killing spore by blocking spore-induced phagocyte cell death; increase activation, production of antimicrobial and cytocidal agents endogenous nitric oxide, inflammatory cytokines |
| 09/04/2008 | US20080213314 Combined dna vaccine and biological modifiers for cancer therapy |
| 09/04/2008 | US20080213310 Use of lytic toxins and toxin conjugates |
| 09/04/2008 | US20080213309 Multi-antigenic alphavirus replicon particles and methods |
| 09/04/2008 | US20080213307 Monoparamunity inducers based on attenuated rabbit myxomaviruses |
| 09/04/2008 | US20080213295 Estrogen receptor polypeptide which induces immune respone; for use in treatment and prevention of cell proliferative disorders; antitumor agents |
| 09/04/2008 | US20080213293 Using papillomavirus minor capsid protein as tool in generating neutralizing antibodies which prevent and treat papillomal infection |
| 09/04/2008 | US20080213290 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 09/04/2008 | US20080213287 Method of inhibiting infection by HCV, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 09/04/2008 | US20080213283 Using interleukin-1 inhibitor as therapeutic agent in treatment of spinal cord injury and nervous system disorders; for example, Pralnacasan (VX-740), thalidomide, pentoxifylline, a lazaroid, cyclosporin A |
| 09/04/2008 | US20080213280 Therapy of autoimmune disease in a patient with an inadequate response to a tnf-alpha inhibitor |
| 09/04/2008 | US20080213278 Using taxol and immunosuppressant administration as therapeutic treatment for immune-mediated and/or cell proliferative disorders |
| 09/04/2008 | US20080213263 Methods and compositions for treatment of immune dysfunction disorders |
| 09/04/2008 | US20080213259 Methods for Treating Autoimmune and Chronic Inflammatory Conditions Using Antagonists of CD30 or CD30L |
| 09/04/2008 | US20080213257 Using cytokine antagonist to treat and prevent rheumatoid arthritis and inflammatory bowel diseases |
| 09/04/2008 | US20080213256 Less Immunogenic Binding Molecules |
| 09/04/2008 | US20080213255 Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin b peptides |
| 09/04/2008 | US20080213254 Immunoglobulin capable of linking immunoreceptor tyrosine-based activation motif (ITAM) with immunoreceptor tyrosine-based inhibition motif (ITIM) for use in treatment of allergic disorders; gene therapy |
| 09/04/2008 | US20080213239 Dietary mixture comprising docosohexaenoic acid, alpha -tocopherol, gamma tocopherol and eicosapentaenoic acid for use in treatment and prevention of inflammatory, rheumatic and cardiovascular disorders |
| 09/04/2008 | US20080213227 Using animal progenitor cell culture to propagate organ tissues; tissue engineering; tissue repair; regenerative medicine; treating cell proliferative, arthritic, autoimmune, skin and inflammatory disorders |
| 09/04/2008 | US20080213216 Transgenic lymphocytes comprising expression vector coding Fc receptor for use in identifying modulators for prevention and treatment of ifection and immune system disorders |
| 09/04/2008 | CA2686840A1 Liposome for induction of cell-mediated immunity |
| 09/04/2008 | CA2679400A1 Combination therapy for treatment of immune disorders |
| 09/04/2008 | CA2679399A1 Antagonist ox40 antibodies and their use in the treatment of inflammatory and autoimmune diseases |
| 09/04/2008 | CA2679126A1 Macrocyclic compound |
| 09/04/2008 | CA2678626A1 Anti-ip-10 antibodies and methods of use thereof |
| 09/04/2008 | CA2677075A1 Method for activation of helper t cell and composition for use in the method |
| 09/03/2008 | EP1964854A2 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions |
| 09/03/2008 | EP1964852A1 Anti-ilt7 antibody |
| 09/03/2008 | EP1964845A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/03/2008 | EP1964844A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/03/2008 | EP1964574A1 Method for treatment or prevention of disease associated with functional disorder of regulatory t cell |
| 09/03/2008 | EP1964573A2 Method of inducing and/or enhancing an immune response to tumor antigens |
| 09/03/2008 | EP1964572A2 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 09/03/2008 | EP1964570A1 Pharmaceutical compound to protect against allergies and inflammatory illnesses |
| 09/03/2008 | EP1964561A1 Inhibitors of IMPDH enzyme |
| 09/03/2008 | EP1963551A1 Markers for memory t cells and uses thereof |
| 09/03/2008 | EP1963508A2 COMPOSITIONS AND METHODS OF USING siRNA TO KNOCKDOWN GENE EXPRESSION AND TO IMPROVE SOLID ORGAN AND CELL TRANSPLANTATION |
| 09/03/2008 | EP1963484A1 Method of producing rough strains of bacteria and uses thereof |
| 09/03/2008 | EP1963328A2 Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 09/03/2008 | EP1963315A2 Enzyme inhibitors |
| 09/03/2008 | EP1963307A1 3- (4- { [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl[0xy] phenyl) -1-piperidinyl carbonyl }-1-naphthalenyl) propanoic or propenoic acid as h1 and h3 receptor antagonists for the treatment of inflammatory and/or allergic disorders |
| 09/03/2008 | EP1963282A1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs |
| 09/03/2008 | EP1962881A2 Random copolymer compositions for treating unwanted immune response |
| 09/03/2008 | EP1962880A2 Methods of treating unwanted immune response with random copolymers |
| 09/03/2008 | EP1817022A4 Methods for increasing the immune response in an animal |
| 09/03/2008 | EP1701933B1 Novel compounds |
| 09/03/2008 | EP1389094B1 Delivery of sedative-hypnotics trough an inhalation route |
| 09/03/2008 | EP1351988B1 Group 2 allergen specific igg molecules and use thereof |
| 09/03/2008 | EP1343781B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/03/2008 | EP1328289B1 Oxidized proteins, their biological activity, and therapeutic and diagnostic measures, which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof |
| 09/03/2008 | EP1299424B1 COLD WATER SOLUBLE $g(b)-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME |
| 09/03/2008 | EP0923940B1 Peptide-based immunotherapeutic agent for allergic diseases |